Moreover, it outperformed other leading HCC risk prediction models, including: aMAP (Age, Male, Albumin–Bilirubin, Platelets), ADRESS-HCC (Age, Diabetes, Race, Etiology, Sex, Severity of cirrhosis), THRI (Toronto Hepatocellular Carcinoma Risk Index), Agile 3+ and Agile 4+ score. The gene discussed is ALB; the disease is hepatocellular carcinoma.